MRMD — Marimed Income Statement
0.000.00%
Last trade - 00:00- $41.98m
- $111.87m
- $157.96m
- 58
- 96
- 26
- 63
Annual income statement for Marimed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 50.9 | 121 | 134 | 149 | 158 |
| Cost of Revenue | |||||
| Gross Profit | 31.3 | 66.3 | 64 | 65.9 | 62.9 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 36.4 | 94.6 | 114 | 145 | 155 |
| Operating Profit | 14.5 | 26.9 | 20.4 | 3.95 | 2.91 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 4.5 | 23.8 | 19.5 | -6.6 | -3.97 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2.43 | 7.62 | 13.6 | -16 | -12.1 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 2.14 | 7.22 | 13.5 | -16 | -12.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2.14 | 7.22 | 13.5 | -16 | -12.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.007 | 0.019 | 0.037 | -0.024 | -0.03 |